Patients with learning disabilities and needle phobia are benefiting from a painless new form of blood sampling pioneered by University Hospitals of Morecambe Bay NHS Foundation Trust.
During a live event, Marc J. Braunstein, MD, PhD, and participants discussed maintenance lenalidomide and daratumumab as well as the clinical potential of MRD in multiple myeloma.
The latest cholesterol guidelines include three new screening tests: coronary artery calcium, lipoprotein (a), and ...
Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source ...
Non-invasive prenatal testing (NIPT) is a simple blood test during pregnancy that helps detect rare genetic conditions early, ...
Mediafeed on MSN
At-home lab tests promise answers—but do they deliver?
This article was reviewed by Darragh O’Carroll, MD. Pros, Cons & Benefits of At-Home Lab Testing You probably don’t have time (or want to) to sit … ...
Heart disease remains the leading cause of death around the world. Every year millions of people die from conditions such as ...
Hands-on, practical education is the hallmark of engineering education at Michigan Tech. So when Samantha Cooper '27 saw the ...
Background Metabolic-associated steatotic liver disease (MASLD) is a prevalent chronic liver disease affecting approximately ...
Learn practical ways to improve the reasoning section for bank exams. Discover topic-wise strategies, time management tips, ...
CancerGuard is a multi-cancer early detection blood test from Exact Sciences that runs through a clinician-ordered lab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results